Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Researchers observed that the peptide has beneficial effects on the dysfunction related to the 5-HT and dopamine systems
Other trials The SURMOUNT-5 head-to-head trial (NCT05822830) compared tirzepatide with semaglutide in adults with obesity who did not have type 2 diabetes
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Originally marketed under the brand name Ozempic for diabetes management, Semaglutide has also been approved for weight management in higher doses under the brand name Wegovy
US$ 27.84
US$ 28.33
US$ 22.12
US$ 28.98
